A citation-based method for searching scientific literature

Francine Baumann, Erin Flores, Andrea Napolitano, Shreya Kanodia, Emanuela Taioli, Harvey Pass, Haining Yang, Michele Carbone. Carcinogenesis 2015
Times Cited: 140







List of co-cited articles
1309 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Germline BAP1 mutations predispose to malignant mesothelioma.
Joseph R Testa, Mitchell Cheung, Jianming Pei, Jennifer E Below, Yinfei Tan, Eleonora Sementino, Nancy J Cox, A Umran Dogan, Harvey I Pass, Sandra Trusa,[...]. Nat Genet 2011
634
55

High Incidence of Somatic BAP1 alterations in sporadic malignant mesothelioma.
Masaki Nasu, Mitsuru Emi, Sandra Pastorino, Mika Tanji, Amy Powers, Hugh Luk, Francine Baumann, Yu-An Zhang, Adi Gazdar, Shreya Kanodia,[...]. J Thorac Oncol 2015
189
39

A Subset of Mesotheliomas With Improved Survival Occurring in Carriers of BAP1 and Other Germline Mutations.
Sandra Pastorino, Yoshie Yoshikawa, Harvey I Pass, Mitsuru Emi, Masaki Nasu, Ian Pagano, Yasutaka Takinishi, Ryuji Yamamoto, Michael Minaai, Tomoko Hashimoto-Tamaoki,[...]. J Clin Oncol 2018
66
51

Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations.
Raphael Bueno, Eric W Stawiski, Leonard D Goldstein, Steffen Durinck, Assunta De Rienzo, Zora Modrusan, Florian Gnad, Thong T Nguyen, Bijay S Jaiswal, Lucian R Chirieac,[...]. Nat Genet 2016
455
32

The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma.
Matthew Bott, Marie Brevet, Barry S Taylor, Shigeki Shimizu, Tatsuo Ito, Lu Wang, Jenette Creaney, Richard A Lake, Maureen F Zakowski, Boris Reva,[...]. Nat Genet 2011
461
30

BAP1 and cancer.
Michele Carbone, Haining Yang, Harvey I Pass, Thomas Krausz, Joseph R Testa, Giovanni Gaudino. Nat Rev Cancer 2013
388
30

Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma.
A Napolitano, L Pellegrini, A Dey, D Larson, M Tanji, E G Flores, B Kendrick, D Lapid, A Powers, S Kanodia,[...]. Oncogene 2016
104
30

BAP1 regulates IP3R3-mediated Ca2+ flux to mitochondria suppressing cell transformation.
Angela Bononi, Carlotta Giorgi, Simone Patergnani, David Larson, Kaitlyn Verbruggen, Mika Tanji, Laura Pellegrini, Valentina Signorato, Federica Olivetto, Sandra Pastorino,[...]. Nature 2017
206
30

Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma.
Vasiliki Panou, Meghana Gadiraju, Arthur Wolin, Caroline M Weipert, Emily Skarda, Aliya N Husain, Jyoti D Patel, Buerkley Rose, Shannon R Zhang, Madison Weatherly,[...]. J Clin Oncol 2018
87
33

Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy.
Raffit Hassan, Betsy Morrow, Anish Thomas, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Meghana Gadiraju, Vasiliki Panou, Shaojian Gao, Idrees Mian,[...]. Proc Natl Acad Sci U S A 2019
69
40

Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair.
Helen Yu, Helen Pak, Ian Hammond-Martel, Mehdi Ghram, Amélie Rodrigue, Salima Daou, Haithem Barbour, Luc Corbeil, Josée Hébert, Elliot Drobetsky,[...]. Proc Natl Acad Sci U S A 2014
217
27

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.
Nicholas J Vogelzang, James J Rusthoven, James Symanowski, Claude Denham, E Kaukel, Pierre Ruffie, Ulrich Gatzemeier, Michael Boyer, Salih Emri, Christian Manegold,[...]. J Clin Oncol 2003
25

Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma.
Guangwu Guo, Juliann Chmielecki, Chandra Goparaju, Adriana Heguy, Igor Dolgalev, Michele Carbone, Sara Seepo, Matthew Meyerson, Harvey I Pass. Cancer Res 2015
196
23

Germline BAP1 mutations induce a Warburg effect.
Angela Bononi, Haining Yang, Carlotta Giorgi, Simone Patergnani, Laura Pellegrini, Mingming Su, Guoxiang Xie, Valentina Signorato, Sandra Pastorino, Paul Morris,[...]. Cell Death Differ 2017
69
33

Germline mutations in BAP1 predispose to melanocytic tumors.
Thomas Wiesner, Anna C Obenauf, Rajmohan Murali, Isabella Fried, Klaus G Griewank, Peter Ulz, Christian Windpassinger, Werner Wackernagel, Shea Loy, Ingrid Wolf,[...]. Nat Genet 2011
467
21

High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma.
Yoshie Yoshikawa, Mitsuru Emi, Tomoko Hashimoto-Tamaoki, Masaki Ohmuraya, Ayuko Sato, Tohru Tsujimura, Seiki Hasegawa, Takashi Nakano, Masaki Nasu, Sandra Pastorino,[...]. Proc Natl Acad Sci U S A 2016
93
21

Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial.
Gérard Zalcman, Julien Mazieres, Jacques Margery, Laurent Greillier, Clarisse Audigier-Valette, Denis Moro-Sibilot, Olivier Molinier, Romain Corre, Isabelle Monnet, Valérie Gounant,[...]. Lancet 2016
503
19

Mesothelioma: Scientific clues for prevention, diagnosis, and therapy.
Michele Carbone, Prasad S Adusumilli, H Richard Alexander, Paul Baas, Fabrizio Bardelli, Angela Bononi, Raphael Bueno, Emanuela Felley-Bosco, Francoise Galateau-Salle, David Jablons,[...]. CA Cancer J Clin 2019
156
19

Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases.
K Rai, R Pilarski, C M Cebulla, M H Abdel-Rahman. Clin Genet 2016
120
18

Combined Genetic and Genealogic Studies Uncover a Large BAP1 Cancer Syndrome Kindred Tracing Back Nine Generations to a Common Ancestor from the 1700s.
Michele Carbone, Erin G Flores, Mitsuru Emi, Todd A Johnson, Tatsuhiko Tsunoda, Dusty Behner, Harriet Hoffman, Mary Hesdorffer, Masaki Nasu, Andrea Napolitano,[...]. PLoS Genet 2015
58
31

Consensus Report of the 2015 Weinman International Conference on Mesothelioma.
Michele Carbone, Shreya Kanodia, Ann Chao, Aubrey Miller, Anil Wali, David Weissman, Alex Adjei, Francine Baumann, Paolo Boffetta, Brenda Buck,[...]. J Thorac Oncol 2016
91
19

BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs.
Michele Carbone, Laura Korb Ferris, Francine Baumann, Andrea Napolitano, Christopher A Lum, Erin G Flores, Giovanni Gaudino, Amy Powers, Peter Bryant-Greenwood, Thomas Krausz,[...]. J Transl Med 2012
193
18

Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group.
Aliya Noor Husain, Thomas V Colby, Nelson G Ordóñez, Timothy Craig Allen, Richard Luther Attanoos, Mary Beth Beasley, Kelly Jo Butnor, Lucian R Chirieac, Andrew M Churg, Sanja Dacic,[...]. Arch Pathol Lab Med 2018
265
18

Integrative Molecular Characterization of Malignant Pleural Mesothelioma.
Julija Hmeljak, Francisco Sanchez-Vega, Katherine A Hoadley, Juliann Shih, Chip Stewart, David Heiman, Patrick Tarpey, Ludmila Danilova, Esther Drill, Ewan A Gibb,[...]. Cancer Discov 2018
258
18

Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of Cancer.
Jill A Ohar, Mitchell Cheung, Jacqueline Talarchek, Suzanne E Howard, Timothy D Howard, Mary Hesdorffer, Hongzhuang Peng, Frank J Rauscher, Joseph R Testa. Cancer Res 2016
61
27

Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma.
Marta Betti, Elisabetta Casalone, Daniela Ferrante, Anna Aspesi, Giulia Morleo, Alessandra Biasi, Marika Sculco, Giuseppe Mancuso, Simonetta Guarrera, Luisella Righi,[...]. Cancer Lett 2017
50
34

Frequent mutation of BAP1 in metastasizing uveal melanomas.
J William Harbour, Michael D Onken, Elisha D O Roberson, Shenghui Duan, Li Cao, Lori A Worley, M Laurin Council, Katie A Matatall, Cynthia Helms, Anne M Bowcock. Science 2010
894
17

BAP1 protein is a progression factor in malignant pleural mesothelioma.
Lisa Arzt, Franz Quehenberger, Iris Halbwedl, Thomas Mairinger, Helmut H Popper. Pathol Oncol Res 2014
54
29

Genotypic and Phenotypic Features of BAP1 Cancer Syndrome: A Report of 8 New Families and Review of Cases in the Literature.
Alexandra M Haugh, Ching-Ni Njauw, Jeffrey A Bubley, Anna Elisa Verzì, Bin Zhang, Emily Kudalkar, Timothy VandenBoom, Kara Walton, Brian L Swick, Raj Kumar,[...]. JAMA Dermatol 2017
52
30

Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers.
Mohamed H Abdel-Rahman, Robert Pilarski, Colleen M Cebulla, James B Massengill, Benjamin N Christopher, Getachew Boru, Peter Hovland, Frederick H Davidorf. J Med Genet 2011
302
15

Loss of expression of BAP1 predicts longer survival in mesothelioma.
Mahtab Farzin, Christopher W Toon, Adele Clarkson, Loretta Sioson, Nicole Watson, Juliana Andrici, Anthony J Gill. Pathology 2015
77
19

BAP1 loss defines a new class of renal cell carcinoma.
Samuel Peña-Llopis, Silvia Vega-Rubín-de-Celis, Arnold Liao, Nan Leng, Andrea Pavía-Jiménez, Shanshan Wang, Toshinari Yamasaki, Leah Zhrebker, Sharanya Sivanand, Patrick Spence,[...]. Nat Genet 2012
604
15

Loss of BAP1 function leads to EZH2-dependent transformation.
Lindsay M LaFave, Wendy Béguelin, Richard Koche, Matt Teater, Barbara Spitzer, Alan Chramiec, Efthymia Papalexi, Matthew D Keller, Todd Hricik, Katerina Konstantinoff,[...]. Nat Med 2015
208
15

Erionite exposure in North Dakota and Turkish villages with mesothelioma.
Michele Carbone, Y Izzettin Baris, Pietro Bertino, Brian Brass, Sabahattin Comertpay, A Umran Dogan, Giovanni Gaudino, Sandro Jube, Shreya Kanodia, Charles R Partridge,[...]. Proc Natl Acad Sci U S A 2011
109
15

Asbestos is not just asbestos: an unrecognised health hazard.
Francine Baumann, Jean-Paul Ambrosi, Michele Carbone. Lancet Oncol 2013
94
15

Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide.
Sebastian Walpole, Antonia L Pritchard, Colleen M Cebulla, Robert Pilarski, Meredith Stautberg, Frederick H Davidorf, Arnaud de la Fouchardière, Odile Cabaret, Lisa Golmard, Dominique Stoppa-Lyonnet,[...]. J Natl Cancer Inst 2018
93
16

BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma.
Stephanie M McGregor, Ryan Dunning, Elizabeth Hyjek, Wickii Vigneswaran, Aliya N Husain, Thomas Krausz. Hum Pathol 2015
78
17

Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline Bap1 Mutations.
Yuwaraj Kadariya, Mitchell Cheung, Jinfei Xu, Jianming Pei, Eleonora Sementino, Craig W Menges, Kathy Q Cai, Frank J Rauscher, Andres J Klein-Szanto, Joseph R Testa. Cancer Res 2016
62
22

BRCA1-Associated Protein 1 (BAP1) Immunohistochemical Expression as a Diagnostic Tool in Malignant Pleural Mesothelioma Classification: A Large Retrospective Study.
Luisella Righi, Eleonora Duregon, Simona Vatrano, Stefania Izzo, Jessica Giorcelli, Milena Rondón-Lagos, Valeria Ascoli, Enrico Ruffini, Laura Ventura, Marco Volante,[...]. J Thorac Oncol 2016
51
27

Germline BAP1 mutations predispose to renal cell carcinomas.
Tatiana Popova, Lucie Hebert, Virginie Jacquemin, Sophie Gad, Virginie Caux-Moncoutier, Catherine Dubois-d'Enghien, Bénédicte Richaudeau, Xavier Renaudin, Jason Sellers, André Nicolas,[...]. Am J Hum Genet 2013
181
14

Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial.
Evan W Alley, Juanita Lopez, Armando Santoro, Anne Morosky, Sanatan Saraf, Bilal Piperdi, Emilie van Brummelen. Lancet Oncol 2017
299
14

BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations.
Marta Cigognetti, Silvia Lonardi, Simona Fisogni, Piera Balzarini, Vilma Pellegrini, Andrea Tironi, Luisa Bercich, Mattia Bugatti, Giulio Rossi, Bruno Murer,[...]. Mod Pathol 2015
152
13

Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey.
I Roushdy-Hammady, J Siegel, S Emri, J R Testa, M Carbone. Lancet 2001
164
13

Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma.
Jinfei Xu, Yuwaraj Kadariya, Mitchell Cheung, Jianming Pei, Jacqueline Talarchek, Eleonora Sementino, Yinfei Tan, Craig W Menges, Kathy Q Cai, Samuel Litwin,[...]. Cancer Res 2014
89
14

Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma.
Yoshie Yoshikawa, Ayuko Sato, Tohru Tsujimura, Mitsuru Emi, Tomonori Morinaga, Kazuya Fukuoka, Shusai Yamada, Aki Murakami, Nobuyuki Kondo, Seiji Matsumoto,[...]. Cancer Sci 2012
124
12

Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience.
D Curran, T Sahmoud, P Therasse, J van Meerbeeck, P E Postmus, G Giaccone. J Clin Oncol 1998
384
12

Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008.
Vanya Delgermaa, Ken Takahashi, Eun-Kee Park, Giang Vinh Le, Toshiyuki Hara, Tom Sorahan. Bull World Health Organ 2011
253
12

HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients.
Andrea Napolitano, Daniel J Antoine, Laura Pellegrini, Francine Baumann, Ian Pagano, Sandra Pastorino, Chandra M Goparaju, Kirill Prokrym, Claudia Canino, Harvey I Pass,[...]. Clin Cancer Res 2016
74
16

Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation.
Haining Yang, Zeyana Rivera, Sandro Jube, Masaki Nasu, Pietro Bertino, Chandra Goparaju, Guido Franzoso, Michael T Lotze, Thomas Krausz, Harvey I Pass,[...]. Proc Natl Acad Sci U S A 2010
176
12

Germline mutations in BAP1 impair its function in DNA double-strand break repair.
Ismail Hassan Ismail, Riley Davidson, Jean-Philippe Gagné, Zhi Zhong Xu, Guy G Poirier, Michael J Hendzel. Cancer Res 2014
125
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.